Identification of a melanoma-associated chondroitin sulfate proteoglycan (MCSP) peptide recognized by CD4<sup>+ </sup>T lymphocytes on human melanoma cells
Main Authors: | Schuler G, Thielemans K, Heirman C, Erfurt CS, Schultz ES |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-07-01
|
Series: | Cancer Cell International |
Similar Items
-
Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth <it>in vitro </it>and <it>in vivo</it>
by: van Waarde Aren, et al.
Published: (2010-11-01) -
Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans
by: Heikki Rauvala, et al.
Published: (2017-01-01) -
Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
by: Justin R. Siebert, et al.
Published: (2014-01-01) -
CD8<sup>+</sup>, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma
by: Guerry DuPont, et al.
Published: (2005-11-01) -
Global analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycans.
by: Panpan Yu, et al.
Published: (2013-01-01)